Hodgkin's Lymphoma: ESMO Clinical Practice Guidelines

Published in 2014 – Ann Oncol (2014) 25 (suppl 3): iii70-iii75

Authors: D. A. Eichenauer, A. Engert, M. André, M. Federico, T. Illidge, M. Hutchings, & M. Ladetto

The 2014 update elaborates on two histologically distinguished entities: classical Hodgkin's lymphoma that accounts about 95% of cases and nodular lymphocyte-predominant Hodgkin's lymphoma, which represents the remainder of cases. The text provides clinical practice recommendations for diagnosis, staging and risk assessment; treatment of limited-, intermediate- and advanced-stage classical Hodgkin lymphoma and relapsed disease; treatment of nodular lymphocyte-predominant Hodgkin lymphoma; and response evaluation, prognosis and follow-up.

Download the PDF from Annals of Oncology
Last update: 25 July 2011